Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Autoimmune Diseases, CNS

Explore clinical trials studying Demyelinating Autoimmune Diseases, CNS. Study availability and eligibility vary by location and protocol.

2,731 public trials 401 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Autoimmune Diseases, CNS trial results

Completed

Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)

NCT04934800

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • KH der Barmherzige Brüder Eisenstadt - Neurology Eisenstadt, Austria
  • Dr. Reinhard Krendl-Head Sankt Veit an der Glan, Austria
  • Klinik Florisdorf Vienna, Austria
  • University of Thrace, Medical School - Neurology Department Alexandroupoli, Greece
View all 61 locations
View Trial Details
Completed

Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis

NCT03232073

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • The Research Center of Southern California, LLC Carlsbad, California, United States
  • The Neurology Group Pomona, California, United States
  • Mountain View Clinical Research Denver, Colorado, United States
  • Neurology Associates of Ormond Beach Ormond Beach, Florida, United States
View all 148 locations
View Trial Details

Related conditions